annb0t
Top 20
MELBOURNE, Australia and DRESDEN, Germany, March 19, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement to commercially partner the QDOSE® dosimetry software platform with ABX-CRO Advanced Pharmaceutical Services Forschungsgesellschaft mbH (ABX-CRO), a full-service contract research organisation (CRO) based in Dresden, and its development partner, Stockholm-based Quantinm AB. (PRNewsfoto/Telix Pharmaceutic...
>>> Read more: QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy
>>> Read more: QDOSE® Platform Partnership for Personalised Dosimetry in Radiopharmaceutical Therapy
